{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:43:39Z","timestamp":1775025819593,"version":"3.50.1"},"reference-count":125,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2014,6,4]]},"DOI":"10.4161\/hv.29352","type":"journal-article","created":{"date-parts":[[2014,5,26]],"date-time":"2014-05-26T19:26:37Z","timestamp":1401132397000},"page":"1582-1594","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":20,"title":["Systematic review of the economic value of diarrheal vaccines"],"prefix":"10.1080","volume":"10","author":[{"given":"Richard","family":"Rheingans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirna","family":"Amaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poulomy","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Atem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,6]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(13)60222-6","article-title":"Global burden of childhood pneumonia and diarrhoea","volume":"381","author":"Walker","year":"2013","journal-title":"Lancet"},{"key":"R2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1542\/peds.2008-1200","article-title":"Burden of acute gastroenteritis hospitalizations and emergency department visits in US children that is potentially preventable by rotavirus vaccination: a probe study using the now-withdrawn rotashield vaccine","volume":"123","author":"Tate","year":"2009","journal-title":"Pediatrics"},{"key":"R3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4161\/hv.28857","article-title":"Rotavirus vaccines: Current status and future considerations","volume":"10","author":"Yen","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"R4","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(13)62630-6","article-title":"Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial","author":"Bhandari","year":"2014","journal-title":"Lancet"},{"key":"R5","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.1016\/j.vaccine.2013.08.008","article-title":"The role of health economic analyses in vaccine decision making","volume":"31","author":"Black","year":"2013","journal-title":"Vaccine"},{"key":"R6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study","volume":"382","author":"Kotloff","year":"2013","journal-title":"Lancet"},{"key":"R7","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1471-2458-13-S3-S11","article-title":"Vaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirus","volume":"13","author":"Das","year":"2013","journal-title":"BMC Public Health"},{"key":"R8","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/aje\/kwt094","article-title":"Diarrhea in early childhood: short-term association with weight and long-term association with length","volume":"178","author":"Richard","year":"2013","journal-title":"Am J Epidemiol"},{"key":"R9","doi-asserted-by":"crossref","first-page":"e47908","DOI":"10.1371\/journal.pone.0047908","article-title":"Does childhood diarrhea influence cognition beyond the diarrhea-stunting pathway?","volume":"7","author":"Fischer Walker","year":"2012","journal-title":"PLoS One"},{"key":"R10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-230X-13-46","article-title":"Pathogen-specific risk of chronic gastrointestinal disorders following bacterial causes of foodborne illness","volume":"13","author":"Porter","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"R11","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.annepidem.2013.03.012","article-title":"Early childhood diarrhea and cardiometabolic risk factors in adulthood: the Institute of Nutrition of Central America and Panama Nutritional Supplementation Longitudinal Study","volume":"23","author":"DeBoer","year":"2013","journal-title":"Ann Epidemiol"},{"key":"R12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3329\/jhpn.v31i3.16515","article-title":"Enteric pathogens and reactive arthritis: a systematic review of Campylobacter, salmonella and Shigella-associated reactive arthritis","volume":"31","author":"Ajene","year":"2013","journal-title":"J Health Popul Nutr"},{"key":"R13","doi-asserted-by":"crossref","first-page":"e003801","DOI":"10.1136\/bmjopen-2013-003801","article-title":"A case-control study of incident rheumatological conditions following acute gastroenteritis during military deployment","volume":"3","author":"Deyoung","year":"2013","journal-title":"BMJ Open"},{"key":"R14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.smim.2013.04.010","article-title":"Valuing the broader benefits of dengue vaccination, with a preliminary application to Brazil","volume":"25","author":"B\u00e4rnighausen","year":"2013","journal-title":"Semin Immunol"},{"key":"R15","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1016\/j.vaccine.2007.04.070","article-title":"Do we fully understand the economic value of vaccines?","volume":"25","author":"Drummond","year":"2007","journal-title":"Vaccine"},{"key":"R16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2458-12-878","article-title":"Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries","volume":"12","author":"Deogaonkar","year":"2012","journal-title":"BMC Public Health"},{"key":"R17","doi-asserted-by":"crossref","first-page":"S317","DOI":"10.1093\/cid\/cis763","article-title":"Exploring household economic impacts of childhood diarrheal illnesses in 3 African settings","volume":"55","author":"Rheingans","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R18","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R19","doi-asserted-by":"crossref","first-page":"7097","DOI":"10.1016\/j.vaccine.2012.09.040","article-title":"The potential economic value of a human norovirus vaccine for the United States","volume":"30","author":"Bartsch","year":"2012","journal-title":"Vaccine"},{"key":"R20","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/j.vaccine.2008.03.008","article-title":"Development of a travelers\u2019 diarrhea vaccine for the military: how much is an ounce of prevention really worth?","volume":"26","author":"Riddle","year":"2008","journal-title":"Vaccine"},{"key":"R21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1524-4733.2007.00220.x","article-title":"Private demand for cholera vaccines in Hue, Vietnam","volume":"11","author":"Kim","year":"2008","journal-title":"Value Health"},{"key":"R22","doi-asserted-by":"crossref","first-page":"e81231","DOI":"10.1371\/journal.pone.0081231","article-title":"An optimal cost effectiveness study on Zimbabwe cholera seasonal data from 2008-2011","volume":"8","author":"Sardar","year":"2013","journal-title":"PLoS One"},{"key":"R23","doi-asserted-by":"crossref","first-page":"e1844","DOI":"10.1371\/journal.pntd.0001844","article-title":"Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar","volume":"6","author":"Schaetti","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"R24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2334-9-65","article-title":"Effectiveness and economic analysis of the whole cell\/recombinant B subunit (WC\/rbs) inactivated oral cholera vaccine in the prevention of traveller\u2019s diarrhoea","volume":"9","author":"L\u00f3pez-Gigosos","year":"2009","journal-title":"BMC Infect Dis"},{"key":"R25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1708-8305.2008.00270.x","article-title":"Cost-benefit of WC\/rBS oral cholera vaccine for vaccination against ETEC-caused travelers\u2019 diarrhea","volume":"16","author":"Lundkvist","year":"2009","journal-title":"J Travel Med"},{"key":"R26","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1469-0691.2004.00901.x","article-title":"Vaccination against typhoid fever in travellers: a cost-effectiveness approach","volume":"10","author":"Papadimitropoulos","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"R27","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1086\/653578","article-title":"The cost-effectiveness of rotavirus vaccination in Malawi","volume":"202","author":"Berry","year":"2010","journal-title":"J Infect Dis"},{"key":"R28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/pam.20401","article-title":"Using private demand studies to calculate socially optimal vaccine subsidies in developing countries","volume":"28","author":"Cook","year":"2009","journal-title":"J Policy Anal Manage"},{"key":"R29","first-page":"711","article-title":"Evaluating investments in typhoid vaccines in two slums in Kolkata, India","volume":"27","author":"Cook","year":"2009","journal-title":"J Health Popul Nutr"},{"key":"R30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/wber\/lhp006","article-title":"A Cost-Benefit Analysis of Cholera Vaccination Programs in Beira, Mozambique","volume":"23","author":"Jeuland","year":"2009","journal-title":"World Bank Econ Rev"},{"key":"R31","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.vaccine.2008.12.032","article-title":"An optimization model for reducing typhoid cases in developing countries without increasing public spending","volume":"27","author":"Lauria","year":"2009","journal-title":"Vaccine"},{"key":"R32","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/aje\/154.11.1077","article-title":"Rotavirus vaccine and intussusception: how much risk will parents in the United States accept to obtain vaccine benefits?","volume":"154","author":"Sansom","year":"2001","journal-title":"Am J Epidemiol"},{"key":"R33","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2165\/11597750-000000000-00000","article-title":"The impact of rotavirus vaccination on discounted net tax revenue in Egypt: a government perspective analysis","volume":"30","author":"Connolly","year":"2012","journal-title":"Pharmacoeconomics"},{"key":"R34","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1016\/j.vaccine.2013.09.002","article-title":"Fiscal consequences of changes in morbidity and mortality attributed to rotavirus immunisation","volume":"31","author":"Kotsopoulos","year":"2013","journal-title":"Vaccine"},{"key":"R35","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1016\/j.vaccine.2010.04.015","article-title":"Rotavirus vaccination in northeast Brazil: a laudable intervention, but can it lead to cost-savings?","volume":"28","author":"Centenari","year":"2010","journal-title":"Vaccine"},{"key":"R36","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1590\/S1020-49892009000600003","article-title":"Economic impact of a rotavirus vaccination program in Mexico","volume":"25","author":"Constenla","year":"2009","journal-title":"Rev Panam Salud Publica"},{"key":"R37","doi-asserted-by":"crossref","first-page":"A15","DOI":"10.1016\/j.vaccine.2012.01.018","article-title":"Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness","volume":"30","author":"Rheingans","year":"2012","journal-title":"Vaccine"},{"key":"R38","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1086\/605058","article-title":"Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya","volume":"200","author":"Tate","year":"2009","journal-title":"J Infect Dis"},{"key":"R39","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1016\/j.vaccine.2013.07.014","article-title":"Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis","volume":"31","author":"Verguet","year":"2013","journal-title":"Vaccine"},{"key":"R40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4269\/ajtmh.12-0629","article-title":"Household environmental conditions are associated with enteropathy and impaired growth in rural Bangladesh","volume":"89","author":"Lin","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"R41","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/ije\/dys233","article-title":"Effect of recent diarrhoeal episodes on risk of pneumonia in children under the age of 5 years in Karachi, Pakistan","volume":"42","author":"Ashraf","year":"2013","journal-title":"Int J Epidemiol"},{"key":"R42","first-page":"41","article-title":"Coping with unreliable public water supplies: Averting expenditures by households in Kathmandu, Nepal","volume":"\u2022\u2022\u2022","author":"Pattanayak","year":"2005","journal-title":"Water Resour Res"},{"key":"R43","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.325_674b","article-title":"Cholera vaccine will reduce antibiotic use","volume":"325","author":"Okeke","year":"2009","journal-title":"Science"},{"key":"R44","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(14)60191-4","article-title":"Team science and the creation of a novel rotavirus vaccine in India: a new framework for vaccine development","author":"Bhan","year":"2014","journal-title":"Lancet"},{"key":"R45","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1016\/j.vaccine.2012.01.076","article-title":"Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction in Ghana","volume":"30","author":"Abbott","year":"2012","journal-title":"Vaccine"},{"key":"R46","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1086\/605033","article-title":"Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries","volume":"200","author":"Atherly","year":"2009","journal-title":"J Infect Dis"},{"key":"R47","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1016\/j.vaccine.2011.12.096","article-title":"Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030","volume":"30","author":"Atherly","year":"2012","journal-title":"Vaccine"},{"key":"R48","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.vaccine.2012.11.071","article-title":"Estimating and comparing the clinical and economic impact of paediatric rotavirus vaccination in Turkey using a simple versus an advanced model","volume":"31","author":"Bakir","year":"2013","journal-title":"Vaccine"},{"key":"R49","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1016\/j.vaccine.2013.08.103","article-title":"Cost-effectiveness of rotavirus vaccination programs in Taiwan","volume":"31","author":"Chang","year":"2013","journal-title":"Vaccine"},{"key":"R50","first-page":"114","article-title":"Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children","volume":"41","author":"Chotivitayatarakorn","year":"2010","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"R51","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1086\/605043","article-title":"Cost-effectiveness of rotavirus vaccination in peru","volume":"200","author":"Clark","year":"2009","journal-title":"J Infect Dis"},{"key":"R52","first-page":"388","article-title":"Economic impact of a rotavirus vaccine in Brazil","volume":"26","author":"Constenla","year":"2008","journal-title":"J Health Popul Nutr"},{"key":"R53","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1016\/j.vaccine.2008.09.040","article-title":"The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries","volume":"26","author":"Cook","year":"2008","journal-title":"Vaccine"},{"key":"R54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3201\/eid2001.130019","article-title":"Dynamic modeling of cost-effectiveness of rotavirus vaccination, Kazakhstan","volume":"20","author":"Freiesleben de Blasio","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"R55","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1016\/j.vaccine.2010.03.004","article-title":"Potential epidemiological and economical impact of two rotavirus vaccines in Colombia","volume":"28","author":"De la Hoz","year":"2010","journal-title":"Vaccine"},{"key":"R56","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1590\/S1020-49892008000400001","article-title":"Cost-effectiveness analysis of routine rotavirus vaccination in Brazil","volume":"23","author":"de So\u00e1rez","year":"2008","journal-title":"Rev Panam Salud Publica"},{"key":"R57","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/cid\/ciq094","article-title":"Projected impact and cost-effectiveness of a rotavirus vaccination program in India, 2008","volume":"52","author":"Esposito","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R58","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1086\/497339","article-title":"Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam","volume":"192","author":"Fischer","year":"2005","journal-title":"J Infect Dis"},{"key":"R59","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1086\/605040","article-title":"Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan","volume":"200","author":"Flem","year":"2009","journal-title":"J Infect Dis"},{"key":"R60","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/adc.2007.117879","article-title":"Rotavirus vaccination for Hong Kong children: an economic evaluation from the Hong Kong Government perspective","volume":"93","author":"Ho","year":"2008","journal-title":"Arch Dis Child"},{"key":"R61","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.vaccine.2006.07.029","article-title":"Rotavirus disease in Uzbekistan: cost-effectiveness of a new vaccine","volume":"25","author":"Isakbaeva","year":"2007","journal-title":"Vaccine"},{"key":"R62","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1524-4733.2009.00562.x","article-title":"Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis","volume":"12","author":"Jeuland","year":"2009","journal-title":"Value Health"},{"key":"R63","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1016\/j.vaccine.2009.02.104","article-title":"Cost-benefit comparisons of investments in improved water supply and cholera vaccination programs","volume":"27","author":"Jeuland","year":"2009","journal-title":"Vaccine"},{"key":"R64","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1016\/j.vaccine.2011.08.127","article-title":"The cost-effectiveness of rotavirus vaccination in Armenia","volume":"29","author":"Jit","year":"2011","journal-title":"Vaccine"},{"key":"R65","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2458-9-29","article-title":"Cost-effectiveness of Rotavirus vaccination in Vietnam","volume":"9","author":"Kim","year":"2009","journal-title":"BMC Public Health"},{"key":"R66","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2458-10-253","article-title":"Health and economic impact of rotavirus vaccination in GAVI-eligible countries","volume":"10","author":"Kim","year":"2010","journal-title":"BMC Public Health"},{"key":"R67","first-page":"659","article-title":"Potential impact of reactive vaccination in controlling cholera outbreaks: an exploratory analysis using a Zimbabwean experience","volume":"101","author":"Kim","year":"2011","journal-title":"S Afr Med J"},{"key":"R68","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2334-11-174","article-title":"Comparative evaluation of the potential impact of rotavirus versus hpv vaccination in GAVI-eligible countries: A preliminary analysis focused on the relative disease burden","volume":"11","author":"Kim","year":"2011","journal-title":"BMC Infect Dis"},{"key":"R69","doi-asserted-by":"crossref","first-page":"6940","DOI":"10.1016\/j.vaccine.2012.05.084","article-title":"Projected health impact and cost-effectiveness of rotavirus vaccination among children <5 years of age in China","volume":"30","author":"Liu","year":"2012","journal-title":"Vaccine"},{"key":"R70","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1016\/j.vaccine.2012.02.047","article-title":"Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand","volume":"30","author":"Muangchana","year":"2012","journal-title":"Vaccine"},{"key":"R71","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1086\/605057","article-title":"Cost-benefit analysis of a rotavirus immunization program in the Arab Republic of Egypt","volume":"200","author":"Ortega","year":"2009","journal-title":"J Infect Dis"},{"key":"R72","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1016\/j.vaccine.2013.10.022","article-title":"Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model","volume":"31","author":"Patel","year":"2013","journal-title":"Vaccine"},{"key":"R73","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1086\/431513","article-title":"Projected cost-effectiveness of rotavirus vaccination for children in Asia","volume":"192","author":"Podewils","year":"2005","journal-title":"J Infect Dis"},{"key":"R74","first-page":"311","article-title":"A cost-benefit analysis of typhoid fever immunization programmes in an Indian urban slum community","volume":"22","author":"Poulos","year":"2004","journal-title":"J Health Popul Nutr"},{"key":"R75","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1086\/605026","article-title":"Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries","volume":"200","author":"Rheingans","year":"2009","journal-title":"J Infect Dis"},{"key":"R76","doi-asserted-by":"crossref","first-page":"b3653","DOI":"10.1136\/bmj.b3653","article-title":"Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis","volume":"339","author":"Rose","year":"2009","journal-title":"BMJ"},{"key":"R77","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1016\/j.vaccine.2011.05.038","article-title":"Cost-effectiveness of rotavirus vaccination in Bolivia from the state perspective","volume":"29","author":"Smith","year":"2011","journal-title":"Vaccine"},{"key":"R78","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1377\/hlthaff.2011.0382","article-title":"Estimated Economic Benefits During The 'Decade Of Vaccines' Include Treatment Savings, Gains In Labor Productivity","volume":"30","author":"Stack","year":"2011","journal-title":"Health Aff"},{"key":"R79","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1016\/j.vaccine.2013.04.055","article-title":"Cost-effectiveness of rotavirus immunization in Indonesia: taking breastfeeding patterns into account","volume":"31","author":"Suwantika","year":"2013","journal-title":"Vaccine"},{"key":"R80","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1016\/j.vaccine.2010.12.122","article-title":"Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda","volume":"29","author":"Tate","year":"2011","journal-title":"Vaccine"},{"key":"R81","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.vaccine.2011.11.052","article-title":"Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries","volume":"30","author":"Tu","year":"2012","journal-title":"Vaccine"},{"key":"R82","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2334-8-103","article-title":"Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico","volume":"8","author":"Valencia-Mendoza","year":"2008","journal-title":"BMC Infect Dis"},{"key":"R83","doi-asserted-by":"crossref","first-page":"e47511","DOI":"10.1371\/journal.pone.0047511","article-title":"A cost effectiveness and capacity analysis for the introduction of universal rotavirus vaccination in Kenya: comparison between Rotarix and RotaTeq vaccines","volume":"7","author":"van Hoek","year":"2012","journal-title":"PLoS One"},{"key":"R84","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1086\/605632","article-title":"Potential cost-effectiveness of a rotavirus immunization program in rural China","volume":"49","author":"Wang","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R85","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.worlddev.2012.03.004","article-title":"Setting Priorities, Targeting Subsidies among Water, Sanitation, and Preventive Health Interventions in Developing Countries","volume":"40","author":"Whittington","year":"2012","journal-title":"World Dev"},{"key":"R86","doi-asserted-by":"crossref","first-page":"F67","DOI":"10.1016\/j.vaccine.2009.09.040","article-title":"Economic evaluation of a routine rotavirus vaccination programme in Indonesia","volume":"27","author":"Wilopo","year":"2009","journal-title":"Vaccine"},{"key":"R87","doi-asserted-by":"crossref","first-page":"6766","DOI":"10.1016\/j.vaccine.2012.09.025","article-title":"The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales","volume":"30","author":"Atkins","year":"2012","journal-title":"Vaccine"},{"key":"R88","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/0272989X08324955","article-title":"Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and \u201cno medical care\u201d disease impact in Belgium","volume":"29","author":"Bilcke","year":"2009","journal-title":"Med Decis Making"},{"key":"R89","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1741-7015-11-112","article-title":"Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination","volume":"11","author":"Bruijning-Verhagen","year":"2013","journal-title":"BMC Med"},{"key":"R90","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/eurpub\/ckp005","article-title":"Potential impact and cost-effectiveness analysis of rotavirus vaccination of children in Israel","volume":"19","author":"Chodick","year":"2009","journal-title":"Eur J Public Health"},{"key":"R91","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1155\/2012\/327054","article-title":"Cost effectiveness of infant vaccination for rotavirus in Canada","volume":"23","author":"Coyle","year":"2012","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"R92","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3111\/13696990802306162","article-title":"Burden of rotavirus gastroenteritis and potential benefits of a pentavalent rotavirus vaccination in Belgium","volume":"11","author":"Dhont","year":"2008","journal-title":"J Med Econ"},{"key":"R93","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2458-10-469","article-title":"Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain","volume":"10","author":"Diez-Domingo","year":"2010","journal-title":"BMC Public Health"},{"key":"R94","doi-asserted-by":"crossref","first-page":"7601","DOI":"10.1016\/j.vaccine.2012.10.034","article-title":"Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: a model-based evaluation","volume":"30","author":"Fisman","year":"2012","journal-title":"Vaccine"},{"key":"R95","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1016\/j.vaccine.2009.04.002","article-title":"An economic analysis of rotavirus vaccination in Italy","volume":"27","author":"Giammanco","year":"2009","journal-title":"Vaccine"},{"key":"R96","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.vaccine.2007.11.070","article-title":"The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands","volume":"26","author":"Goossens","year":"2008","journal-title":"Vaccine"},{"key":"R97","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1016\/j.vaccine.2007.06.015","article-title":"Burden of paediatric rotavirus gastroenteritis and potential benefits of a universal rotavirus vaccination programme with RotaTeq in France","volume":"25","author":"Huet","year":"2007","journal-title":"Vaccine"},{"key":"R98","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ypmed.2013.12.013","article-title":"Budget impact and cost-utility analysis of universal infant rotavirus vaccination in Spain","volume":"61","author":"Imaz","year":"2014","journal-title":"Prev Med"},{"key":"R99","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1016\/j.vaccine.2007.02.070","article-title":"Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination","volume":"25","author":"Jit","year":"2007","journal-title":"Vaccine"},{"key":"R100","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.1016\/j.vaccine.2009.08.030","article-title":"The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe","volume":"27","author":"Jit","year":"2009","journal-title":"Vaccine"},{"key":"R101","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/1010539511416806","article-title":"Economic evaluation of the national immunization program of rotavirus vaccination for children in Korea","volume":"25","author":"Kang","year":"2013","journal-title":"Asia Pac J Public Health"},{"key":"R102","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1017\/S0950268807008151","article-title":"Exploring the cost effectiveness of an immunization programme for rotavirus gastroenteritis in the United Kingdom","volume":"136","author":"Lorgelly","year":"2008","journal-title":"Epidemiol Infect"},{"key":"R103","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/j.vaccine.2010.01.014","article-title":"Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program?","volume":"28","author":"Mangen","year":"2010","journal-title":"Vaccine"},{"key":"R104","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1016\/j.vaccine.2009.05.006","article-title":"Cost-effectiveness of infant vaccination with RIX4414 (Rotarix) in the UK","volume":"27","author":"Martin","year":"2009","journal-title":"Vaccine"},{"key":"R105","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.vaccine.2007.11.064","article-title":"Cost and cost-effectiveness of childhood vaccination against rotavirus in France","volume":"26","author":"Melliez","year":"2008","journal-title":"Vaccine"},{"key":"R106","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1524-4733.2009.00534.x","article-title":"Budget impact and cost-effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization schedule","volume":"12","author":"Milne","year":"2009","journal-title":"Value Health"},{"key":"R107","doi-asserted-by":"crossref","first-page":"8851","DOI":"10.1016\/j.vaccine.2007.10.009","article-title":"The cost-effectiveness of rotavirus vaccination in Australia","volume":"25","author":"Newall","year":"2007","journal-title":"Vaccine"},{"key":"R108","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1016\/j.vaccine.2009.01.054","article-title":"Burden of rotavirus disease and cost-effectiveness of universal vaccination in the Province of Genoa (Northern Italy)","volume":"27","author":"Panatto","year":"2009","journal-title":"Vaccine"},{"key":"R109","first-page":"166","article-title":"Socio-economic modelling of rotavirus vaccination in Castilla y Leon, Spain","volume":"19","author":"P\u00e9rez-Rubio","year":"2011","journal-title":"Infez Med"},{"key":"R110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2458-11-462","article-title":"Consensus Grp Dutch R. Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model","volume":"11","author":"Rozenbaum","year":"2011","journal-title":"BMC Public Health"},{"key":"R111","doi-asserted-by":"crossref","first-page":"277","DOI":"10.7883\/yoken.64.277","article-title":"Cost-effectiveness analysis of a universal rotavirus immunization program in Japan","volume":"64","author":"Sato","year":"2011","journal-title":"Jpn J Infect Dis"},{"key":"R112","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1016\/j.vaccine.2009.04.030","article-title":"Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination","volume":"27","author":"Shim","year":"2009","journal-title":"Vaccine"},{"key":"R113","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF03256134","article-title":"Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France","volume":"6","author":"Standaert","year":"2008","journal-title":"Appl Health Econ Health Policy"},{"key":"R114","doi-asserted-by":"crossref","first-page":"e53864","DOI":"10.1371\/journal.pone.0053864","article-title":"Impact of rotavirus vaccination on hospitalisations in Belgium: comparing model predictions with observed data","volume":"8","author":"Standaert","year":"2013","journal-title":"PLoS One"},{"key":"R115","doi-asserted-by":"crossref","unstructured":"Syriopoulou V, Kafetzis D, Theodoridou M, Syrogiannopoulos GA, Mantagos S, Trimis G, Mavrikou M, Konstantopoulos A. Evaluation of potential medical and economic benefits of universal rotavirus vaccination in Greece. Acta paediatrica (Oslo, Norway: 1992) 2011; 100:732-9.","DOI":"10.1111\/j.1651-2227.2010.02127.x"},{"key":"R116","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1016\/j.vaccine.2011.07.056","article-title":"Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland","volume":"29","author":"Tilson","year":"2011","journal-title":"Vaccine"},{"key":"R117","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2334-13-54","article-title":"An update of \u201cCost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model\u201d","volume":"13","author":"Tu","year":"2013","journal-title":"BMC Infect Dis"},{"key":"R118","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1542\/peds.2009-1246","article-title":"Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States","volume":"125","author":"Wang","year":"2010","journal-title":"Pediatrics"},{"key":"R119","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1016\/j.vaccine.2009.06.025","article-title":"Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq","volume":"27","author":"Weycker","year":"2009","journal-title":"Vaccine"},{"key":"R120","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1542\/peds.2006-2876","article-title":"Cost-effectiveness and potential impact of rotavirus vaccination in the United States","volume":"119","author":"Widdowson","year":"2007","journal-title":"Pediatrics"},{"key":"R121","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.vaccine.2009.01.023","article-title":"Cost-effectiveness of childhood rotavirus vaccination in Taiwan","volume":"27","author":"Wu","year":"2009","journal-title":"Vaccine"},{"key":"R122","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1542\/peds.2013-0698","article-title":"Economic evaluation of the routine childhood immunization program in the United States, 2009","volume":"133","author":"Zhou","year":"2014","journal-title":"Pediatrics"},{"key":"R123","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2334-13-112","article-title":"The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infections","volume":"13","author":"Zlamy","year":"2013","journal-title":"BMC Infect Dis"},{"key":"R124","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1016\/j.vaccine.2008.04.039","article-title":"Assessing the introduction of universal rotavirus vaccination in the Netherlands","volume":"26","author":"Zomer","year":"2008","journal-title":"Vaccine"},{"key":"R125","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.1016\/j.vaccine.2010.08.060","article-title":"An update to \u201cThe cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe\u201d","volume":"28","author":"Jit","year":"2010","journal-title":"Vaccine"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.4161\/hv.29352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T19:26:04Z","timestamp":1649100364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4161\/hv.29352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":125,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,3,18]]},"published-print":{"date-parts":[[2014,6,4]]}},"alternative-id":["10.4161\/hv.29352"],"URL":"https:\/\/doi.org\/10.4161\/hv.29352","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}